Structural bases for Na<sup>+</sup>-Cl<sup>-</sup> cotransporter inhibition by thiazide diuretic drugs and activation by kinases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39143061.
- Also identified by DOI 10.1038/s41467-024-51381-y and PMC identifier 11324901.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Na<sup>+</sup>-Cl<sup>-</sup> cotransporter (NCC) drives salt reabsorption in the kidney and plays a decisive role in balancing electrolytes and blood pressure. Thiazide and thiazide-like diuretics inhibit NCC-mediated renal salt retention and have been cornerstones for treating hypertension and edema since the 1950s. Here we determine NCC co-structures individually complexed with the thiazide drug hydrochlorothiazide, and two thiazide-like drugs chlorthalidone and indapamide, revealing that they fit into an orthosteric site and occlude the NCC ion translocation pathway. Aberrant NCC activation by the WNKs-SPAK kinase cascade underlies Familial Hyperkalemic Hypertension, but it remains unknown whether/how phosphorylation transforms the NCC structure to accelerate ion translocation. We show that an intracellular amino-terminal motif of NCC, once phosphorylated, associates with the carboxyl-terminal domain, and together, they interact with the transmembrane domain. These interactions suggest a phosphorylation-dependent allosteric network that directly influences NCC ion translocation.
Medical subject headings
- Solute Carrier Family 12, Member 3
- Hydrochlorothiazide
- Sodium Chloride Symporter Inhibitors